Back to top
more

Evolent Health (EVH)

(Real Time Quote from BATS)

$28.04 USD

28.04
182,913

+0.39 (1.41%)

Updated Apr 29, 2024 12:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 252)

Industry: Internet - Software

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Evolent Health (EVH) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Evolent Health (EVH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are Options Traders Betting on a Big Move in Evolent Health (EVH) Stock?

by Zacks Equity Research

Investors need to pay close attention to Evolent Health (EVH) stock based on the movements in the options market lately.

Will Evolent Health (EVH) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Evolent Health (EVH) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Evolent Health (EVH) delivered earnings and revenue surprises of -75.00% and 1.47%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Company News for Nov 29, 2019

by Zacks Equity Research

Companies In The News Are: CENT, BOX, DPLO, EVH

Options Traders Expect Huge Moves in Evolent Health (EVH) Stock

by Zacks Equity Research

Investors need to pay close attention to Evolent Health (EVH) stock based on the movements in the options market lately.

Evolent Health (EVH) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Evolent Health (EVH) delivered earnings and revenue surprises of 40.00% and 1.31%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Evolent Health (EVH) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Implied Volatility Surging for Evolent Health (EVH) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Evolent Health (EVH) stock based on the movements in the options market lately.

Evolent Health (EVH) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

Evolent Health (EVH) delivered earnings and revenue surprises of -13.04% and -0.19%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Evolent Health (EVH) Q2 Earnings Expected to Decline

by Zacks Equity Research

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Evolent Health (EVH) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Evolent Health (EVH) delivered earnings and revenue surprises of 8.82% and 2.91%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Evolent Health (EVH) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Evolent Health (EVH) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Evolent Health (EVH) delivered earnings and revenue surprises of -75.00% and 2.36%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Evolent Health (EVH) Looks Good: Stock Adds 6.4% in Session

by Zacks Equity Research

Evolent Health (EVH) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Why Evolent Health (EVH) Isn't Done Growing Earnings Yet

by Zacks Equity Research

Evolent Health (EVH) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

Evolent Health (EVH) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Evolent Health (EVH) delivered earnings and revenue surprises of 20.00% and 5.10%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Evolent Health (EVH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

by Zacks Equity Research

Evolent Health (EVH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Evolent Health (EVH) Looks Good: Stock Adds 5.5% in Session

by Zacks Equity Research

Evolent Health (EVH) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

    Evolent Health (EVH) Reports Q2 Loss, Tops Revenue Estimates

    by Zacks Equity Research

    Evolent Health (EVH) delivered earnings and revenue surprises of 25.00% and 1.84%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

      Has Evolent Health (EVH) Outpaced Other Computer and Technology Stocks This Year?

      by Zacks Equity Research

      Is (EVH) Outperforming Other Computer and Technology Stocks This Year?

        Evolent Health (EVH) Posts Q2 Loss as Expected, Revenues Top

        by Zacks Equity Research

        Evolent Health's (EVH) strong rise in the number of members on its platform was the key highlight of the second quarter.

          Evolent Health (EVH) Prices 4.5M Follow-On Share Offering

          by Zacks Equity Research

          Evolent Health, Inc. (EVH) recently announced the pricing of its follow-on public offering of 4.5 million shares of Class A common stock at $25.90 per share.

            Evolent Health (EVH) Prices 7M Follow-On Share Offering

            by Zacks Equity Research

            Evolent Health, Inc. (EVH) recently announced the pricing of its follow-on public offering of 7.5 million shares of Class A common stock at $24.65 per share.

              Evolent Health (EVH) Prices 7.5M Follow-On Share Offering

              by Zacks Equity Research

              Evolent Health, Inc. (EVH) announced the pricing of its follow-on public offering of 7.5 million shares of Class A common stock at $21.25 per share.